Диагностическое значение магнитно-резонансной томографии при гипертрофии миокарда левого желудочка различного генеза. Литературный обзор

Диагностическое значение магнитно-резонансной томографии при гипертрофии миокарда левого желудочка различного генеза. Литературный обзор

Автор: Ларина Ольга Михайловна

Журнал: Вестник Российского научного центра рентгенорадиологии Минздрава России @vestnik-rncrr

Рубрика: Обзоры

Статья в выпуске: 1 т.10, 2010 года.

Бесплатный доступ

Работа посвящена патофизиологическим механизмам развития гипертрофической кардиомиопатии, оценке методов диагностики гипертрофии миокарда ЛЖ, возможностям метода магнитно-резонансной томографии с контрастированием для выявления фиброзных изменений в миокарде ЛЖ.

Гипертрофическая кардиомиопатия, магнитно-резонансная томография, левый желудочек

Короткий адрес: https://sciup.org/14955196

IDR: 14955196

Список литературы Диагностическое значение магнитно-резонансной томографии при гипертрофии миокарда левого желудочка различного генеза. Литературный обзор

  • Беленков Ю.Н., Привалова Е.В., Каплунова В.Ю., Стамбольский Д.В., Фомин А.А. Гипертрофическая кардиомиопатия -исторические и современные взгляды на диагностику заболевания//Кардиология и сердечно-сосудистая хирургия.-2008.-№4. -С. 4-10.
  • Беленков Ю.Н., Терновой С.К., Синицын В.Е. Магнитно-резонансная томография сердца и сосудов//М. -Видар. -1997. -С.142.
  • Грамович В.В., Синицын В.Е., Гордин М.П. и соавт. Количественная оценка перфузии миокарда с помощью магнитно-резонансной томографии//Кардиология.-2004.-№ 8. -С. 4-12.
  • Ринкк П.А. Магнитный резонанс в медицине//М.-Геотар-Мед. -2003.
  • Синицын В.Е., Терновой С.К. Магнитно-резонансная томография в новом столетии//Радиология-практика.-2005.-№ 4. -С. 17-22.
  • Allison J.D., Flickinger F.W., Wright J.C., Falls D.G., 3rd, Prisant L.M., VonDohlen T.W., Frank M.J. Measurement of left ventricular mass in hypertrophic cardiomyopathy using MRI: comparison with echocardiography//Magn Reson Imaging.-1993.-Vol. 11. -P. 329-334.
  • Amano Y., Takayama M., Amano M., Kumazaki T. MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy//AJR Am J Roentgenol.-2004.-Vol. 182. -P. 523-527.
  • Amano Y., Takayama M., Takahama K., Kumazaki T. Delayed hyper-enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: comparison with global and regional cardiac MR imaging appearances//J Magn Reson Imaging.-2004.-Vol. 20. -P. 595-600.
  • Anan R., Greve G., Thierfelder L., Watkins H., McKenna W.J., Solomon S., Vecchio C., Shono H., Nakao S., Tanaka H., et al. Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy//J Clin Invest.-1994.-Vol. 93. -P. 280-285.
  • Andersen K., Hennersdorf M., Cohnen M., Blondin D., Modder U., Poll L.W. Myocardial delayed contrast enhancement in patients with arterial hypertension: Initial results of cardiac MRI//Eur J Radiol.-2008.-Vol. -P.
  • Arrive L., Assayag P., Russ G., Najmark D., Brochet E., Nahum H. MRI and cine MRI of asymmetric septal hypertrophic cardiomyopathy//J Comput Assist Tomogr.-1994.-Vol. 18. -P. 376-382.
  • Autore C., Bernabo P., Barilla C.S., Bruzzi P., Spirito P. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms//J Am Coll Cardiol.-2005.-Vol. 45. -P. 1076-1080.
  • Autore C., Quarta G., Spirito P. Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy//Curr Treat Options Cardiovasc Med.-2007.-Vol. 9. -P. 431-435.
  • Bahl O.P., Walsh T.J., Massie E. Electrocardiography and vectorcardiography in idiopathic hypertrophic subaortic stenosis//Am J Med Sci.-1970.-Vol. 259. -P. 262-271.
  • Basso C., Thiene G., Corrado D., Buja G., Melacini P., Nava A. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia//Hum Pathol.-2000.-Vol. 31. -P. 988-998.
  • Been M., Kean D., Smith M.A., Douglas R.H., Best J.J., Muir A.L. Nuclear magnetic resonance in hypertrophic cardiomyopathy//Br Heart J.-1985.-Vol. 54. -P. 48-52.
  • Bello D., Shah D.J., Farah G.M., Di Luzio S., Parker M., Johnson M.R., Cotts W.G., Klocke F.J., Bonow R.O., Judd R.M., Gheorghiade M., Kim R.J. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy//Circulation.-2003.-Vol. 108. -P. 1945-1953.
  • Bogaert J., Dymarkowski S. Delayed contrast-enhanced MRI: use in myocardial viability assessment and other cardiac pathology//Eur Radiol.-2005.-Vol. 15 Suppl 2. -P. B52-58.
  • Bogaert J., Goldstein M., Tannouri F., Golzarian J., Dymarkowski S. Original report. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging//AJR Am J Roentgenol.-2003.-Vol. 180. -P. 981-985.
  • Bogaert J., Taylor A.M., Van Kerkhove F., Dymarkowski S. Use of inversion recovery contrast-enhanced MRI for cardiac imaging: spectrum of applications//AJR Am J Roentgenol.-2004.-Vol. 182. -P. 609-615.
  • Cannon R.O., 3rd, Rosing D.R., Maron B.J., Leon M.B., Bonow R.O., Watson R.M., Epstein S.E. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures//Circulation.-1985.-Vol. 71. -P. 234-243.
  • Cecchi F., Olivotto I., Montereggi A., Squillatini G., Dolara A., Maron B.J. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population//Heart.-1998.-Vol. 79. -P. 331-336.
  • Cerqueira M.D., Weissman N.J., Dilsizian V., Jacobs A.K., Kaul S., Laskey W.K., Pennell D.J., Rumberger J.A., Ryan T., Verani M.S. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association//Circulation.-2002.-Vol. 105. -P. 539-542.
  • Chandra M., Silverman M.E., Oshinski J., Pettigrew R. Diagnosis of cardiac sarcoidosis aided by MRI//Chest.-1996.-Vol. 110. -P. 562-565.
  • Choudhury L., Mahrholdt H., Wagner A., Choi K.M., Elliott M.D., Klocke F.J., Bonow R.O., Judd R.M., Kim R.J. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy//J Am Coll Cardiol.-2002.-Vol. 40. -P. 2156-2164.
  • Corrado D., Basso C., Schiavon M., Thiene G. Screening for hypertrophic cardiomyopathy in young athletes//N Engl J Med.-1998.-Vol. 339. -P. 364-369.
  • Cosio F.G., Moro C., Alonso M., de la Calzada C.S., Liovet A. The Q waves hypertrophic cardiomyopathy: an electrophysiologic study//N Engl J Med.-1980.-Vol. 302. -P. 96-99.
  • Crilley J.G., Boehm E.A., Blair E., Rajagopalan B., Blamire A.M., Styles P., McKenna W.J., Ostman-Smith I., Clarke K., Watkins H. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy//J Am Coll Cardiol.-2003.-Vol. 41. -P. 1776-1782.
  • Debl K., Djavidani B., Buchner S., Lipke C., Nitz W., Feuerbach S., Riegger G., Luchner A. Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis//Heart.-2006.-Vol. 92. -P. 1447-1451.
  • Diez J. Diagnosis and treatment of myocardial fibrosis in hypertensive heart disease//Circ J.-2008.-Vol. 72 Suppl A. -P. A8-A12.
  • Diez J., Lopez B., Gonzalez A., Querejeta R. Clinical aspects of hypertensive myocardial fibrosis//Curr Opin Cardiol.-2001.-Vol. 16. -P. 328-335.
  • Dimitrow P.P., Klimeczek P., Vliegenthart R., Pasowicz M., Oudkerk M., Podolec P., Tracz W., Dubiel J.S. Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia//Int J Cardiovasc Imaging.-2008.-Vol. 24. -P. 77-83; discussion 85-77.
  • Dong S.J., MacGregor J.H., Crawley A.P., McVeigh E., Belenkie I., Smith E.R., Tyberg J.V., Beyar R. Left ventricular wall thickness and regional systolic function in patients with hypertrophic cardiomyopathy. A three-dimensional tagged magnetic resonance imaging study//Circulation.-1994.-Vol. 90. -P. 1200-1209.
  • Dulce M.C., Duerinckx A.J., Hartiala J., Caputo G.R., O'Sullivan M., Cheitlin M.D., Higgins C.B. MR imaging of the myocardium using nonionic contrast medium: signal-intensity changes in patients with subacute myocardial infarction//AJR Am J Roentgenol.-1993.-Vol. 160. -P. 963-970.
  • Dumont C.A., Monserrat L., Soler R., Rodriguez E., Fernandez X., Peteiro J., Bouzas B., Pinon P., Castro-Beiras A. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy]//Rev Esp Cardiol.-2007.-Vol. 60. -P. 15-23.
  • Dupuis J.M., Victor J., Furber A., Pezard P., Lejeune L.L., Tadei A. [Value of magnetic resonance imaging in cardiac sarcoidosis. Apropos of a case]//Arch Mal Coeur Vaiss.-1994.-Vol. 87. -P. 105-110.
  • Edelman R.R. Contrast-enhanced MR imaging of the heart: overview of the literature//Radiology.-2004.-Vol. 232. -P. 653-668.
  • Elliott P.M., Gimeno Blanes J.R., Mahon N.G., Poloniecki J.D., McKenna W.J. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy//Lancet.-2001.-Vol. 357. -P. 420-424.
  • Elliott P.M., Gimeno J.R., Tome M.T., Shah J., Ward D., Thaman R., Mogensen J., McKenna W.J. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy//Eur Heart J.-2006.-Vol. 27. -P. 1933-1941.
  • Elliott P.M., Poloniecki J., Dickie S., Sharma S., Monserrat L., Varnava A., Mahon N.G., McKenna W.J. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients//J Am Coll Cardiol.-2000.-Vol. 36. -P. 2212-2218.
  • Elliott P.M., Sharma S., Varnava A., Poloniecki J., Rowland E., McKenna W.J. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy//J Am Coll Cardiol.-1999.-Vol. 33. -P. 1596-1601.
  • Factor S.M., Butany J., Sole M.J., Wigle E.D., Williams W.C., Rojkind M. Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy//J Am Coll Cardiol.-1991.-Vol. 17. -P. 1343-1351.
  • Farmer D., Higgins C.B., Yee E., Lipton M.J., Wahr D., Ports T. Tissue characterization by magnetic resonance imaging in hypertrophic cardiomyopathy//Am J Cardiol.-1985.-Vol. 55. -P. 230-232.
  • Feldman A.M., McNamara D. Myocarditis//N Engl J Med.-2000.-Vol. 343. -P. 1388-1398.
  • Ferrans V.J., Morrow A.G., Roberts W.C. Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. A study of operatively excised left ventricular outflow tract muscle in 14 patients//Circulation.-1972.-Vol. 45. -P. 769-792.
  • Frank H., Globits S. Magnetic resonance imaging evaluation of myocardial and pericardial disease//J Magn Reson Imaging.-1999.-Vol. 10. -P. 617-626.
  • Frenneaux M.P., Counihan P.J., Caforio A.L., Chikamori T., McKenna W.J. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy//Circulation.-1990.-Vol. 82. -P. 1995-2002.
  • Frohlich E.D. State of the Art lecture. Risk mechanisms in hypertensive heart disease//Hypertension.-1999.-Vol. 34. -P. 782-789.
  • Frohlich E.D. Ischemia and fibrosis: the risk mechanisms of hypertensive heart disease//Braz J Med Biol Res.-2000.-Vol. 33. -P. 693-700.
  • Frohlich E.D. Fibrosis and ischemia: the real risks in hypertensive heart disease//Am J Hypertens.-2001.-Vol. 14. -P. 194S-199S.
  • Gaudio C., Pelliccia F., Tanzilli G., Mazzarotto P., Cianfrocca C., Marino B. Magnetic resonance imaging for assessment of apical hypertrophy in hypertrophic cardiomyopathy//Clin Cardiol.-1992.-Vol. 15. -P. 164-168.
  • Gerber B.L., Belge B., Legros G.J., Lim P., Poncelet A., Pasquet A., Gisellu G., Coche E., Vanoverschelde J.L. Characterization of acute and chronic myocardial infarcts by multidetector computed tomography: comparison with contrast-enhanced magnetic resonance//Circulation.-2006.-Vol. 113. -P. 823-833.
  • Gupta A., Lee V.S., Chung Y.C., Babb J.S., Simonetti O.P. Myocardial infarction: optimization of inversion times at delayed contrast-enhanced MR imaging//Radiology.-2004.-Vol. 233. -P. 921-926.
  • Gutberlet M A.H., Hausmann H, et al. Value of Gd-DTPA "late enhancement" in MRI in comparison with gated SPECT for the assessment of myocardial viability: initial results in patients with impaired LV-function//Radiology.-2001.-Vol. 221(P). -P.
  • Harris K.M., Spirito P., Maron M.S., Zenovich A.G., Formisano F., Lesser J.R., Mackey-Bojack S., Manning W.J., Udelson J.E., Maron B.J. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy//Circulation.-2006.-Vol. 114. -P. 216-225.
  • Higgins C.B., Byrd B.F., 3rd, Stark D., McNamara M., Lanzer P., Lipton M.J., Schiller N.B., Botvinick E., Chatterjee K. Magnetic resonance imaging in hypertrophic cardiomyopathy//Am J Cardiol.-1985.-Vol. 55. -P. 1121-1126.
  • Hunold P., Brandt-Mainz K., Freudenberg L., Vogt F.M., Neumann T., Knipp S., Barkhausen J. [Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging-comparison of the late enhancement technique with positronemission tomography]//Rofo.-2002.-Vol. 174. -P. 867-873.
  • Hunold P., Schlosser T., Vogt F.M., Eggebrecht H., Schmermund A., Bruder O., Schuler W.O., Barkhausen J. Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease//AJR Am J Roentgenol.-2005.-Vol. 184. -P. 1420-1426.
  • Kellman P., Arai A.E., McVeigh E.R., Aletras A.H. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement//Magn Reson Med.-2002.-Vol. 47. -P. 372-383.
  • Kellman P., Larson A.C., Hsu L.Y., Chung Y.C., Simonetti O.P., McVeigh E.R., Arai A.E. Motion-corrected free-breathing delayed enhancement imaging of myocardial infarction//Magn Reson Med.-2005.-Vol. 53. -P. 194-200.
  • Kim D.H., Choi S.I., Chang H.J., Choi D.J., Lim C., Park J.H. Delayed hyperenhancement by contrast-enhanced magnetic resonance imaging: Clinical application for various cardiac diseases//J Comput Assist Tomogr.-2006.-Vol. 30. -P. 226-232.
  • Kim R.J., Fieno D.S., Parrish T.B., Harris K., Chen E.L., Simonetti O., Bundy J., Finn J.P., Klocke F.J., Judd R.M. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function//Circulation.-1999.-Vol. 100. -P. 1992-2002.
  • Kim R.J., Judd R.M. Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death?//J Am Coll Cardiol.-2003.-Vol. 41. -P. 1568-1572.
  • Kim R.J., Judd R.M., Chen E.L., Fieno D.S., Parrish T.B., Lima J.A. Relationship of elevated 23Na magnetic resonance image intensity to infarct size after acute reperfused myocardial infarction//Circulation.-1999.-Vol. 100. -P. 185-192.
  • Klein C., Nekolla S.G., Bengel F.M., Momose M., Sammer A., Haas F., Schnackenburg B., Delius W., Mudra H., Wolfram D., Schwaiger M. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography//Circulation.-2002.-Vol. 105. -P. 162-167.
  • Klues H.G., Schiffers A., Maron B.J. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients//J Am Coll Cardiol.-1995.-Vol. 26. -P. 1699-1708.
  • Knaapen P., van Dockum W.G., Bondarenko O., Kok W.E., Gotte M.J., Boellaard R., Beek A.M., Visser C.A., van Rossum A.C., Lammertsma A.A., Visser F.C. Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET//J Nucl Med.-2005.-Vol. 46. -P. 923-929.
  • Knaapen P., van Dockum W.G., Gotte M.J., Broeze K.A., Kuijer J.P., Zwanenburg J.J., Marcus J.T., Kok W.E., van Rossum A.C., Lammertsma A.A., Visser F.C. Regional heterogeneity of resting perfusion in hypertrophic cardiomyopathy is related to delayed contrast enhancement but not to systolic function: a PET and MRI study//J Nucl Cardiol.-2006.-Vol. 13. -P. 660-667.
  • Kobayashi H., Nakata T., Han S., Takahashi N., Hashimoto A., Tsuchihashi K., Nagao K., Tanaka S., Shimamoto K., Iimura O. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid]//J Cardiol.-1994.-Vol. 24. -P. 35-43.
  • Kofflard M.J., Waldstein D.J., Vos J., ten Cate F.J. Prognosis in hypertrophic cardiomyopathy observed in a large clinic population//Am J Cardiol.-1993.-Vol. 72. -P. 939-943.
  • Krams R., Kofflard M.J., Duncker D.J., Von Birgelen C., Carlier S., Kliffen M., ten Cate F.J., Serruys P.W. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation//Circulation.-1998.-Vol. 97. -P. 230-233.
  • Krombach G.A., Niendorf T., Gunther R.W., Mahnken A.H. Characterization of myocardial viability using MR and CT imaging//Eur Radiol.-2007.-Vol. 17. -P. 1433-1444.
  • Kuhl H.P., Beek A.M., van der Weerdt A.P., Hofman M.B., Visser C.A., Lammertsma A.A., Heussen N., Visser F.C., van Rossum A.C. Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography//J Am Coll Cardiol.-2003.-Vol. 41. -P. 1341-1348.
  • Kuhl H.P., Papavasiliu T.S., Beek A.M., Hofman M.B., Heusen N.S., van Rossum A.C. Myocardial viability: rapid assessment with delayed contrast-enhanced MR imaging with three-dimensional inversion-recovery prepared pulse sequence//Radiology.-2004.-Vol. 230. -P. 576-582.
  • Kwong R.Y., Falk R.H. Cardiovascular magnetic resonance in cardiac amyloidosis//Circulation.-2005.-Vol. 111. -P. 122-124.
  • Laissy J.P., Messin B., Varenne O., Iung B., Karila-Cohen D., Schouman-Claeys E., Steg P.G. MRI of acute myocarditis: a comprehensive approach based on various imaging sequences//Chest.-2002.-Vol. 122. -P. 1638-1648.
  • Lee V.S., Resnick D., Tiu S.S., Sanger J.J., Nazzaro C.A., Israel G.M., Simonetti O.P. MR imaging evaluation of myocardial viability in the setting of equivocal SPECT results with (99m)Tc sestamibi//Radiology.-2004.-Vol. 230. -P. 191-197.
  • Lemery R., Kleinebenne A., Nihoyannopoulos P., Aber V., Alfonso F., McKenna W.J. Q waves in hypertrophic cardiomyopathy in relation to the distribution and severity of right and left ventricular hypertrophy//J Am Coll Cardiol.-1990.-Vol. 16. -P. 368-374.
  • Maceira A.M., Joshi J., Prasad S.K., Moon J.C., Perugini E., Harding I., Sheppard M.N., Poole-Wilson P.A., Hawkins P.N., Pennell D.J. Cardiovascular magnetic resonance in cardiac amyloidosis//Circulation.-2005.-Vol. 111. -P. 186-193.
  • Mahnken A.H., Gunther R.W., Krombach G. [Contrast-enhanced MR and MSCT for the assessment of myocardial viability]//Rofo.-2006.-Vol. 178. -P. 771-780.
  • Mahnken A.H., Koos R., Katoh M., Wildberger J.E., Spuentrup E., Buecker A., Gunther R.W., Kuhl H.P. Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging//J Am Coll Cardiol.-2005.-Vol. 45. -P. 2042-2047.
  • Mahrholdt H., Goedecke C., Wagner A., Meinhardt G., Athanasiadis A., Vogelsberg H., Fritz P., Klingel K., Kandolf R., Sechtem U. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology//Circulation.-2004.-Vol. 109. -P. 1250-1258.
  • Mahrholdt H., Wagner A., Judd R.M., Sechtem U., Kim R.J. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies//Eur Heart J.-2005.-Vol. 26. -P. 1461-1474.
  • Marian A.J., Roberts R. Recent advances in the molecular genetics of hypertrophic cardiomyopathy//Circulation.-1995.-Vol. 92. -P. 1336-1347.
  • Maron B.J. Q waves in hypertrophic cardiomyopathy: a reassessment//J Am Coll Cardiol.-1990.-Vol. 16. -P. 375-376.
  • Maron B.J. Hypertrophic cardiomyopathy//Lancet.-1997.-Vol. 350. -P. 127-133.
  • Maron B.J. Cardiology patient pages. Hypertrophic cardiomyopathy//Circulation.-2002.-Vol. 106. -P. 2419-2421.
  • Maron B.J. Hypertrophic cardiomyopathy: a systematic review//Jama.-2002.-Vol. 287. -P. 1308-1320.
  • Maron B.J. Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy//Cardiol Rev.-2002.-Vol. 10. -P. 173-181.
  • Maron B.J. [Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy]//Rev Esp Cardiol.-2006.-Vol. 59. -P. 527-530.
  • Maron B.J., Anan T.J., Roberts W.C. Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy//Circulation.-1981.-Vol. 63. -P. 882-894.
  • Maron B.J., Bonow R.O., Cannon R.O., 3rd, Leon M.B., Epstein S.E. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1)//N Engl J Med.-1987.-Vol. 316. -P. 780-789.
  • Maron B.J., Casey S.A., Poliac L.C., Gohman T.E., Almquist A.K., Aeppli D.M. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort//Jama.-1999.-Vol. 281. -P. 650-655.
  • Maron B.J., Cecchi F., McKenna W.J. Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy//Br Heart J.-1994.-Vol. 72. -P. S13-18.
  • Maron B.J., Epstein S.E., Roberts W.C. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries//Am J Cardiol.-1979.-Vol. 43. -P. 1086-1102.
  • Maron B.J., Estes N.A., 3rd, Maron M.S., Almquist A.K., Link M.S., Udelson J.E. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy//Circulation.-2003.-Vol. 107. -P. 2872-2875.
  • Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults//Circulation.-1995.-Vol. 92. -P. 785-789.
  • Maron B.J., Gottdiener J.S., Epstein S.E. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients//Am J Cardiol.-1981.-Vol. 48. -P. 418-428.
  • Maron B.J., Lipson L.C., Roberts W.C., Savage D.D., Epstein S.E. "Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death//Am J Cardiol.-1978.-Vol. 41. -P. 1133-1140.
  • Maron B.J., Maron M.S., Lesser J.R., Hauser R.G., Haas T.S., Harrigan C.J., Appelbaum E., Main M.L., Roberts W.C. Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status//Am J Cardiol.-2008.-Vol. 101. -P. 544-547.
  • Maron B.J., McKenna W.J., Danielson G.K., Kappenberger L.J., Kuhn H.J., Seidman C.E., Shah P.M., Spencer W.H., 3rd, Spirito P., Ten Cate F.J., Wigle E.D. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines//J Am Coll Cardiol.-2003.-Vol. 42. -P. 1687-1713.
  • Maron B.J., Moller J.H., Seidman C.E., Vincent G.M., Dietz H.C., Moss A.J., Towbin J.A., Sondheimer H.M., Pyeritz R.E., McGee G., Epstein A.E. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and marfan syndrome: A statement for healthcare professionals from the councils on clinical cardiology, cardiovascular disease in the young, and basic science, american heart association//Circulation.-1998.-Vol. 98. -P. 1460-1471.
  • Maron B.J., Niimura H., Casey S.A., Soper M.K., Wright G.B., Seidman J.G., Seidman C.E. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations//J Am Coll Cardiol.-2001.-Vol. 38. -P. 315-321.
  • Maron B.J., Roberts W.C. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy//Circulation.-1979.-Vol. 59. -P. 689-706.
  • Maron B.J., Savage D.D., Wolfson J.K., Epstein S.E. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study//Am J Cardiol.-1981.-Vol. 48. -P. 252-257.
  • Maron B.J., Shen W.K., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., Bardy G.H., Favale S., Rea R.F., Boriani G., Estes N.A., 3rd, Spirito P. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy//N Engl J Med.-2000.-Vol. 342. -P. 365-373.
  • Maron B.J., Shirani J., Poliac L.C., Mathenge R., Roberts W.C., Mueller F.O. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles//Jama.-1996.-Vol. 276. -P. 199-204.
  • Maron B.J., Spirito P. Implications of left ventricular remodeling in hypertrophic cardiomyopathy//Am J Cardiol.-1998.-Vol. 81. -P. 1339-1344.
  • Maron B.J., Spirito P., Shen W.K., Haas T.S., Formisano F., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., Lawrenz T., Boriani G., Estes N.A., 3rd, Favale S., Piccininno M., Winters S.L., Santini M., Betocchi S., Arribas F., Sherrid M.V., Buja G., Semsarian C., Bruzzi P. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy//Jama.-2007.-Vol. 298. -P. 405-412.
  • Maron B.J., Wolfson J.K., Ciro E., Spirito P. Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy//Am J Cardiol.-1983.-Vol. 51. -P. 189-194.
  • Maron M.S., Olivotto I., Betocchi S., Casey S.A., Lesser J.R., Losi M.A., Cecchi F., Maron B.J. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy//N Engl J Med.-2003.-Vol. 348. -P. 295-303.
  • Masui T., Finck S., Higgins C.B. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging//Radiology.-1992.-Vol. 182. -P. 369-373.
  • Matsuki M., Matsuo M. MR findings of myocardial sarcoidosis//Clin Radiol.-2000.-Vol. 55. -P. 323-325.
  • Matsunaka T., Hamada M., Matsumoto Y., Higaki J. First-pass myocardial perfusion defect and delayed contrast enhancement in hypertrophic cardiomyopathy assessed with MRI//Magn Reson Med Sci.-2003.-Vol. 2. -P. 61-69.
  • Matsuo S., Nakamura Y., Takahashi M., Mitsunami K., Kinoshita M. Myocardial metabolic abnormalities in hypertrophic cardiomyopathy assessed by iodine-123-labeled beta-methyl-branched fatty acid myocardial scintigraphy and its relation to exercise-induced ischemia//Jpn Circ J.-1998.-Vol. 62. -P. 167-172.
  • McCrohon J.A., Moon J.C., Prasad S.K., McKenna W.J., Lorenz C.H., Coats A.J., Pennell D.J. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance//Circulation.-2003.-Vol. 108. -P. 54-59.
  • McKenna W., Deanfield J., Faruqui A., England D., Oakley C., Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features//Am J Cardiol.-1981.-Vol. 47. -P. 532-538.
  • McKenna W.J., Borggrefe M., England D., Deanfield J., Oakley C.M., Goodwin J.F. The natural history of left ventricular hypertrophy in hypertrophic cardiomyopathy: an electrocardiographic study//Circulation.-1982.-Vol. 66. -P. 1233-1240.
  • McKenna W.J., England D., Doi Y.L., Deanfield J.E., Oakley C., Goodwin J.F. Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis//Br Heart J.-1981.-Vol. 46. -P. 168-172.
  • McKenna W.J., Franklin R.C., Nihoyannopoulos P., Robinson K.C., Deanfield J.E. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy//J Am Coll Cardiol.-1988.-Vol. 11. -P. 147-153.
  • McKenna W.J., Sadoul N., Slade A.K., Saumarez R.C. The prognostic significance of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy//Circulation.-1994.-Vol. 90. -P. 3115-3117.
  • Miller M.A., Gomes J.A., Fuster V. Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy//Nat Clin Pract Cardiovasc Med.-2007.-Vol. 4. -P. 667-676.
  • Monserrat L., Elliott P.M., Gimeno J.R., Sharma S., Penas-Lado M., McKenna W.J. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients//J Am Coll Cardiol.-2003.-Vol. 42. -P. 873-879.
  • Moon J.C., McKenna W.J., McCrohon J.A., Elliott P.M., Smith G.C., Pennell D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance//J Am Coll Cardiol.-2003.-Vol. 41. -P. 1561-1567.
  • Moon J.C., Mogensen J., Elliott P.M., Smith G.C., Elkington A.G., Prasad S.K., Pennell D.J., McKenna W.J. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I//Heart.-2005.-Vol. 91. -P. 1036-1040.
  • Moon J.C., Reed E., Sheppard M.N., Elkington A.G., Ho S.Y., Burke M., Petrou M., Pennell D.J. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy//J Am Coll Cardiol.-2004.-Vol. 43. -P. 2260-2264.
  • Motoyasu M., Kurita T., Onishi K., Uemura S., Tanigawa T., Okinaka T., Takeda K., Nakano T., Ito M., Sakuma H. Correlation between late gadolinium enhancement and diastolic function in hypertrophic cardiomyopathy assessed by magnetic resonance imaging//Circ J.-2008.-Vol. 72. -P. 378-383.
  • Myerson S.G., Bellenger N.G., Pennell D.J. Assessment of left ventricular mass by cardiovascular magnetic resonance//Hypertension.-2002.-Vol. 39. -P. 750-755.
  • Nicod P., Polikar R., Peterson K.L. Hypertrophic cardiomyopathy and sudden death//N Engl J Med.-1988.-Vol. 318. -P. 1255-1257.
  • Niimura H., Patton K.K., McKenna W.J., Soults J., Maron B.J., Seidman J.G., Seidman C.E. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly//Circulation.-2002.-Vol. 105. -P. 446-451.
  • Nishimura T., Nagata S., Uehara T., Morozumi T., Ishida Y., Nakata T., Iimura O., Kurata C., Wakabayashi Y., Sugihara H., Otsuki K., Wada T., Koga Y. Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography//Ann Nucl Med.-1996.-Vol. 10. -P. 71-78.
  • O'Gara P.T., Bonow R.O., Maron B.J., Damske B.A., Van Lingen A., Bacharach S.L., Larson S.M., Epstein S.E. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography//Circulation.-1987.-Vol. 76. -P. 1214-1223.
  • Ohtsuki K., Sugihara H., Taniguchi Y., Umamoto I., Nakagawa T., Nakamura T., Azuma A., Kohno Y., Adachi H., Ochiai M., et al. [Evaluation of myocardial perfusion and ventricular shape in hypertrophic cardiomyopathy using 99mTc-tetrofosmin scintigraphy: comparison with 201Tl myocardial scintigraphy]//Kaku Igaku.-1994.-Vol. 31. -P. 309-318.
  • Olivotto I., Gistri R., Petrone P., Pedemonte E., Vargiu D., Cecchi F. Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy//J Am Coll Cardiol.-2003.-Vol. 41. -P. 315-321.
  • Papavassiliu T., Schnabel P., Schroder M., Borggrefe M. CMR scarring in a patient with hypertrophic cardiomyopathy correlates well with histological findings of fibrosis//Eur Heart J.-2005.-Vol. 26. -P. 2395.
  • Paya E., Marin F., Gonzalez J., Gimeno J.R., Feliu E., Romero A., Ruiz-Espejo F., Roldan V., Climent V., de la Morena G., Valdes M. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications//J Card Fail.-2008.-Vol. 14. -P. 414-419.
  • Rickers C., Wilke N.M., Jerosch-Herold M., Casey S.A., Panse P., Panse N., Weil J., Zenovich A.G., Maron B.J. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy//Circulation.-2005.-Vol. 112. -P. 855-861.
  • Romano R., Losi M.A., Migliore T., Contaldi C., Parrella L.S., Caputi A., Betocchi S. Evaluation of the left ventricular anatomy in hypertrophic cardiomyopathy: comparison between echocardiography and cardiac magnetic resonance imaging//Minerva Cardioangiol.-2008.-Vol. 56. -P. 181-187.
  • Sadoul N., Prasad K., Elliott P.M., Bannerjee S., Frenneaux M.P., McKenna W.J. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy//Circulation.-1997.-Vol. 96. -P. 2987-2991.
  • Schulz-Menger J., Strohm O., Dietz R., Friedrich M.G. Visualization of cardiac involvement in patients with systemic sarcoidosis applying contrast-enhanced magnetic resonance imaging//Magma.-2000.-Vol. 11. -P. 82-83.
  • Schvartzman PR S.M., Brunken R, et al. Delayed-enhancement (DE) MR: comparison with dobutamine stress echo (DSE), positron emission tomography (PET), and contraction/perfusion MRI for determination of myocardial viability.//Circulation.-2001.-Vol. 104(suppl 17). -P. 534.
  • Schwartz K., Carrier L., Guicheney P., Komajda M. Molecular basis of familial cardiomyopathies//Circulation.-1995.-Vol. 91. -P. 532-540.
  • Shah et al. In: Edelman RR e.a., eds. Clinical Magnetic Resonance Imaging, 3rd ed.//New York: Elsevier Press.-2005.-Vol. -P.
  • Shimizu M., Yoshio H., Ino H., Taki J., Nakajima K., Bunko H., Takeda R. Myocardial scintigraphic study with 123I 15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid in patients with hypertrophic cardiomyopathy//Int J Cardiol.-1996.-Vol. 54. -P. 51-59.
  • Silka M.J., Kron J., Dunnigan A., Dick M., 2nd. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society//Circulation.-1993.-Vol. 87. -P. 800-807.
  • Silverman K.J., Hutchins G.M., Bulkley B.H. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis//Circulation.-1978.-Vol. 58. -P. 1204-1211.
  • Simonetti O.P., Kim R.J., Fieno D.S., Hillenbrand H.B., Wu E., Bundy J.M., Finn J.P., Judd R.M. An improved MR imaging technique for the visualization of myocardial infarction//Radiology.-2001.-Vol. 218. -P. 215-223.
  • Sipola P., Lauerma K., Husso-Saastamoinen M., Kuikka J.T., Vanninen E., Laitinen T., Manninen H., Niemi P., Peuhkurinen K., Jaaskelainen P., Laakso M., Kuusisto J., Aronen H.J. First-pass MR imaging in the assessment of perfusion impairment in patients with hypertrophic cardiomyopathy and the Asp175Asn mutation of the alpha-tropomyosin gene//Radiology.-2003.-Vol. 226. -P. 129-137.
  • Sipola P., Lauerma K., Jaaskelainen P., Laakso M., Peuhkurinen K., Manninen H., Aronen H.J., Kuusisto J. Cine MR imaging of myocardial contractile impairment in patients with hypertrophic cardiomyopathy attributable to Asp175Asn mutation in the alpha-tropomyosin gene//Radiology.-2005.-Vol. 236. -P. 815-824.
  • Sipola P., Vanninen E., Aronen H.J., Lauerma K., Simula S., Jaaskelainen P., Laakso M., Peuhkurinen K., Kuusisto J., Kuikka J.T. Cardiac adrenergic activity is associated with left ventricular hypertrophy in genetically homogeneous subjects with hypertrophic cardiomyopathy//J Nucl Med.-2003.-Vol. 44. -P. 487-493.
  • Soler R., Rodriguez E., Monserrat L., Mendez C., Martinez C. Magnetic resonance imaging of delayed enhancement in hypertrophic cardiomyopathy: relationship with left ventricular perfusion and contractile function//J Comput Assist Tomogr.-2006.-Vol. 30. -P. 412-420.
  • Sotgia B., Sciagra R., Olivotto I., Casolo G., Rega L., Betti I., Pupi A., Camici P.G., Cecchi F. Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy//J Nucl Med.-2008.-Vol. 49. -P. 1090-1096.
  • Spirito P., Bellone P., Harris K.M., Bernabo P., Bruzzi P., Maron B.J. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy//N Engl J Med.-2000.-Vol. 342. -P. 1778-1785.
  • Spirito P., Chiarella F., Carratino L., Berisso M.Z., Bellotti P., Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population//N Engl J Med.-1989.-Vol. 320. -P. 749-755.
  • Spirito P., Maron B.J. Significance of left ventricular outflow tract cross-sectional area in hypertrophic cardiomyopathy: a two-dimensional echocardiographic assessment//Circulation.-1983.-Vol. 67. -P. 1100-1108.
  • Spirito P., Maron B.J. Sudden death and hypertrophic cardiomyopathy//Lancet.-2001.-Vol. 357. -P. 1975-1976.
  • Spirito P., Maron B.J., Bonow R.O., Epstein S.E. Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy//J Am Coll Cardiol.-1986.-Vol. 8. -P. 537-544.
  • Spirito P., Rapezzi C., Autore C., Bruzzi P., Bellone P., Ortolani P., Fragola P.V., Chiarella F., Zoni-Berisso M., Branzi A., et al. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia//Circulation.-1994.-Vol. 90. -P. 2743-2747.
  • Spirito P., Seidman C.E., McKenna W.J., Maron B.J. The management of hypertrophic cardiomyopathy//N Engl J Med.-1997.-Vol. 336. -P. 775-785.
  • Sugihara H., Taniguchi Y., Ohtsuki K., Umamoto I., Nakazawa T., Shima T., Nakamura T., Azuma A., Kohno Y., Nakagawa M. [Assessment of myocardial perfusion abnormalities in patients with apical hypertrophic cardiomyopathy using exercise 201Tl scintigraphy]//Kokyu To Junkan.-1993.-Vol. 41. -P. 1089-1093.
  • Tanaka M., Fujiwara H., Onodera T., Wu D.J., Hamashima Y., Kawai C. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy//Br Heart J.-1986.-Vol. 55. -P. 575-581.
  • Tanaka M., Fujiwara H., Onodera T., Wu D.J., Matsuda M., Hamashima Y., Kawai C. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy//Circulation.-1987.-Vol. 75. -P. 1130-1139.
  • 163 Tuunanen H., Kuusisto J., Toikka J., Jaaskelainen P., Marjamaki P., Peuhkurinen K., Viljanen T., Sipola P., Stolen K.Q., Hannukainen J., Nuutila P., Laakso M., Knuuti J. Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study //J Nucl Cardiol.- 2007.- Vol. 14. - P. 354-365. 164 vanden Driesen R.I., Slaughter R.E., Strugnell W.E. MR findings in cardiac amyloidosis //AJR Am J Roentgenol.- 2006.- Vol. 186. - P. 1682-1685.
  • Varnava A.M., Elliott P.M., Mahon N., Davies M.J., McKenna W.J. Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy//Am J Cardiol.-2001.-Vol. 88. -P. 275-279.
  • Vignaux O., Dhote R., Duboc D., Blanche P., Dusser D., Weber S., Legmann P. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study//Chest.-2002.-Vol. 122. -P. 1895-1901.
  • Virmani R., Bures J.C., Roberts W.C. Cardiac sarcoidosis; a major cause of sudden death in young individuals//Chest.-1980.-Vol. 77. -P. 423-428.
  • Vogel-Claussen J., Rochitte C.E., Wu K.C., Kamel I.R., Foo T.K., Lima J.A., Bluemke D.A. Delayed enhancement MR imaging: utility in myocardial assessment//Radiographics.-2006.-Vol. 26. -P. 795-810.
  • Wagner A., Mahrholdt H., Holly T.A., Elliott M.D., Regenfus M., Parker M., Klocke F.J., Bonow R.O., Kim R.J., Judd R.M. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study//Lancet.-2003.-Vol. 361. -P. 374-379.
  • Wigle E.D., Heimbecker R.O., Gunton R.W. Idiopathic ventricular septal hypertrophy causing muscular subaortic stenosis//Circulation.-1962.-Vol. 26. -P. 325-340.
  • Wu E., Judd R.M., Vargas J.D., Klocke F.J., Bonow R.O., Kim R.J. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction//Lancet.-2001.-Vol. 357. -P. 21-28.
  • Yamazaki T., Suzuki J., Shimamoto R., Tsuji T., Ohmoto Y., Toyo-oka T., Omata M., Ohtomo K., Nagai R. Focalized contractile impairment at hypertrophied myocardium proven in consideration of wall stress in patients with hypertrophic cardiomyopathy//Int Heart J.-2006.-Vol. 47. -P. 247-258.
  • Zamorano J., Delgado J., Almeria C., Moreno R., Gomez Sanchez M., Rodrigo J., Fernandez C., Ferreiros J., Rufilanchas J., Sanchez-Harguindey L. Reason for discrepancies in identifying myocardial viability by thallium-201 redistribution, magnetic resonance imaging, and dobutamine echocardiography//Am J Cardiol.-2002.-Vol. 90. -P. 455-459.
Еще
Статья обзорная
SciUp 2024 © 2024 ©